The burgeoning opioid epidemic takes a devastating toll on patients, their families and their communities. Ending it requires strong leadership and collaboration from all stakeholders, working together at the national, state and community levels. America’s hospitals are playing a key role in the search for solutions. This week, for example, Steven Diaz, M.D. – the senior vice president and chief medical officer for MaineGeneral Health in Augusta – testified before the Senate Special Committee on Aging on the alarming impact of opioid overdosing among the elderly and the need for a multidisciplinary approach to treating chronic pain. Among other issues, Diaz voiced concerns over how the Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) pain questions may contribute to the opioid epidemic. Additionally, AHA supports the Centers for Disease Control and Prevention’s efforts to develop guidance for prescribing opioids for chronic pain. We’re also working to ensure hospitals nationwide have the tools needed to respond to this multifaceted epidemic and have launched a webpage linking to resources on opioid abuse that also will highlight innovative efforts by state hospital associations. And, we are encouraged by the movement of bipartisan legislation, S.524, expected to reach the Senate floor as soon as next week. The bill would require development of pain management guidelines and provide grants to states for education, treatment and alternatives to incarceration. 

Related News Articles

Headline
The Food and Drug Administration Sept. 10 released draft guidance on non-opioid treatments for treating chronic pain and reducing prescription opioid misuse.…
Headline
A Health Affairs study published Sept. 2 found that less than 40% of Medicare beneficiaries with opioid use disorder received standard care in alignment with…
Headline
The Food and Drug Administration July 31 announced that it is requiring safety label changes to all opioid pain medications to further emphasize and explain…
Headline
Overdose deaths in the U.S. fell 26.9% last year to 80,391, according to estimates from the Centers for Disease Control and Prevention. The agency reported…
Headline
The Food and Drug Administration Jan. 30 announced it approved Journavx (suzetrigine) oral tablets, a first-in-class non-opioid drug, to treat moderate to…
Headline
In this conversation, Vinnidhy Dave, D.O., hospice specialist and director of palliative medicine at Englewood Health Physician Network, and Lauren Savage,…